QA: Akorn INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000003116_2017_Akorn_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000003116, Akorn INC

  xvar xval
0 AssetsCurrent 685,811,000
1 IntangibleAssetsNetIncludingGoodwill 1,043,147,000
2 PropertyPlantAndEquipmentNet 238,404,000
3 remainder_Assets 6,358,000
4 LiabilitiesCurrent 175,555,000
5 LiabilitiesNoncurrent 978,981,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 572,809,165
8 SellingGeneralAndAdministrativeExpense 288,799,091
9 ResearchAndDevelopmentExpense 45,248,935
10 remainder_Expenses 224,998,747
11 remainder_Revenues 1,420,278,635
12 remainder_NetIncome -44,764,181
13 remainder_ComprehensiveNetIncome -4,942,943
  yvar yval
0 Assets 1,973,720,000
1 Liabilities 1,154,536,000
2 Expenses 1,131,855,938
3 Revenues 1,420,278,635
4 StockholdersEquity 819,184,000
5 NetIncome 243,658,516
6 ComprehensiveNetIncome 241,187,044
7 BaseVar 2,865,048,848
8 EconomicCapitalRatiobeforeLimitedLiability 1.30
9 EconomicCapitalRatio 2.53

Edgar->Model Mapping

Feature Distribution

Change over Time